These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12551866)

  • 1. Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I Study (Evaluation of Nifedipine and Cerivastatin On Recovery of coronary Endothelial function).
    ENCORE Investigators
    Circulation; 2003 Jan; 107(3):422-8. PubMed ID: 12551866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study.
    Lüscher TF; Pieper M; Tendera M; Vrolix M; Rutsch W; van den Branden F; Gil R; Bischoff KO; Haude M; Fischer D; Meinertz T; Münzel T
    Eur Heart J; 2009 Jul; 30(13):1590-7. PubMed ID: 19474053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with cerivastatin and nifedipine improves endothelial dysfunction after balloon injury in porcine coronary arteries.
    Eto Y; Shimokawa H; Fukumoto Y; Matsumoto Y; Morishige K; Kunihiro I; Kandabashi T; Takeshita A
    J Cardiovasc Pharmacol; 2005 Jul; 46(1):1-6. PubMed ID: 15965348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intense cholesterol lowering therapy with a HMG-CoA reductase inhibitor does not improve nitric oxide dependent endothelial function in type-2-diabetes--a multicenter, randomised, double-blind, three-arm placebo-controlled clinical trial.
    Balletshofer BM; Goebbel S; Rittig K; Enderle M; Schmölzer I; Wascher TC; Ferenc Pap A; Westermeier T; Petzinna D; Matthaei S; Häring HU
    Exp Clin Endocrinol Diabetes; 2005 Jun; 113(6):324-30. PubMed ID: 15977099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of nifedipine on vasodilator response to acetylcholine in coronary and brachial arteries in the patients with coronary artery disease.
    Takase B; Hamabe A; Satomura K; Akima T; Uehata A; Ohsuzu F; Ishihara M; Kurita A
    Int J Cardiol; 2006 Nov; 113(3):305-10. PubMed ID: 16386809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cerivastatin on forearm vascular responses, blood pressure responsiveness and ambulatory blood pressure in type 2 diabetic men.
    Tran D; Lowy A; Howes JB; Howes LG
    Diabetes Obes Metab; 2005 May; 7(3):273-81. PubMed ID: 15811145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks.
    John S; Delles C; Jacobi J; Schlaich MP; Schneider M; Schmitz G; Schmieder RE
    J Am Coll Cardiol; 2001 Apr; 37(5):1351-8. PubMed ID: 11300446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ezetimibe in Combination With Statins Ameliorates Endothelial Dysfunction in Coronary Arteries After Stenting: The CuVIC Trial (Effect of Cholesterol Absorption Inhibitor Usage on Target Vessel Dysfunction After Coronary Stenting), a Multicenter Randomized Controlled Trial.
    Takase S; Matoba T; Nakashiro S; Mukai Y; Inoue S; Oi K; Higo T; Katsuki S; Takemoto M; Suematsu N; Eshima K; Miyata K; Yamamoto M; Usui M; Sadamatsu K; Satoh S; Kadokami T; Hironaga K; Ichi I; Todaka K; Kishimoto J; Egashira K; Sunagawa K
    Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):350-358. PubMed ID: 27932353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function.
    Wassmann S; Faul A; Hennen B; Scheller B; Böhm M; Nickenig G
    Circ Res; 2003 Oct; 93(9):e98-103. PubMed ID: 14551237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidized-LDL levels are changed during short-term serum glucose variations and lowered with statin treatment in early Type 2 diabetes: a study of endothelial function and microalbuminuria.
    Paniagua JA; López-Miranda J; Pérez-Martínez P; Marín C; Vida JM; Fuentes F; Fernández de la Puebla RA; Pérez-Jiménez F
    Diabet Med; 2005 Dec; 22(12):1647-56. PubMed ID: 16401307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetrical dimethylarginine (ADMA) and coronary endothelial function in patients with coronary artery disease and mild hypercholesterolemia.
    Maas R; Quitzau K; Schwedhelm E; Spieker L; Rafflenbeul W; Steenpass A; Lüscher TF; Böger RH
    Atherosclerosis; 2007 Mar; 191(1):211-9. PubMed ID: 16828780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days.
    Tsunekawa T; Hayashi T; Kano H; Sumi D; Matsui-Hirai H; Thakur NK; Egashira K; Iguchi A
    Circulation; 2001 Jul; 104(4):376-9. PubMed ID: 11468195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of cerivastatin 0.8 mg in patients with hypercholesterolaemia: the pivotal placebo-controlled clinical trial. Cerivastatin Study Group.
    Insull W; Isaacsohn J; Kwiterovich P; Ra P; Brazg R; Dujovne C; Shan M; Shugrue-Crowley E; Ripa S; Tota R
    J Int Med Res; 2000; 28(2):47-68. PubMed ID: 10898118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.
    Treasure CB; Klein JL; Weintraub WS; Talley JD; Stillabower ME; Kosinski AS; Zhang J; Boccuzzi SJ; Cedarholm JC; Alexander RW
    N Engl J Med; 1995 Feb; 332(8):481-7. PubMed ID: 7830728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of drug-drug interaction between cerivastatin and nifedipine.
    Sachse R; Brendel E; Mück W; Rohde G; Ochmann K; Horstmann R; Kuhlmann J
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):409-13. PubMed ID: 9726692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential in vitro response of the human radial artery versus left internal thoracic artery to cerivastatin: implications to bypass grafting.
    Nakamura K; Al-Ruzzeh S; Chester AH; Ilsley C; Yacoub MH; Amrani M
    Ann Thorac Surg; 2003 Dec; 76(6):2023-8. PubMed ID: 14667634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cerivastatin therapy on vascular responses to endothelin antagonists in humans.
    Leslie SJ; Spratt JC; Grieg L; Attina T; Denvir MA; Webb DJ
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S410-2. PubMed ID: 15838335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mild endurance exercise training and pravastatin on peripheral vasodilatation of forearm resistance vessels in patients with coronary artery disease.
    Allemann Y; Vetter C; Kartal N; Eyer S; Stengel SM; Saner H; Hess OM
    Eur J Cardiovasc Prev Rehabil; 2005 Aug; 12(4):332-40. PubMed ID: 16079640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early effects of statin therapy on endothelial function and microvascular reactivity in patients with coronary artery disease.
    Ling MC; Ruddy TD; deKemp RA; Ukkonen H; Duchesne L; Higginson L; Williams KA; McPherson R; Beanlands R
    Am Heart J; 2005 Jun; 149(6):1137. PubMed ID: 15976803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients.
    John S; Schneider MP; Delles C; Jacobi J; Schmieder RE
    Am Heart J; 2005 Mar; 149(3):473. PubMed ID: 15864218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.